Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Adjunctive GLP1 Receptor Agonists in Patients with Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2026
1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort study
The lancet. Diabetes & endocrinology, 2026
Aesthetic Use of Poly-L-Lactic Acid and Hyaluronic Acid Fillers in Medication-Driven Weight Loss Due to GLP-1 Receptor Agonists: Real-World Case Series from Latin America
Clinical, cosmetic and investigational dermatology, 2026;19:620566
ATR-FTIR spectroscopy coupled with multivariate analysis for monitoring degradation and secondary structure transitions in therapeutic peptide formulations
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2026;363(Pt 1):128280
Pharmacological mechanisms and clinical impacts of antidiabetic drugs on colorectal cancer risk: a systematic review
Frontiers in pharmacology, 2026;17:1849647
Beyond weight loss: predictors of treatment satisfaction and patient-reported outcomes in incretin-based therapies. A cross-sectional study
Frontiers in endocrinology, 2026;17:1864209
Off-label GLP-1 receptor agonist and tirzepatide use for weight loss: patient safety and regulatory oversight
Annals of medicine and surgery (2012), 2026;88(7):3948-3950
Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS survey
Obesity pillars, 2026;19:100288
[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 2]
Revista medica de Chile, 2026;154(4):564-576
The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients
Schizophrenia bulletin;52(3)
Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management
American family physician;113(6):578-585
Cost-Effectiveness of Pharmacologic Treatments in Adults With Overweight or Obesity: A Systematic Review for the American College of Physicians
Annals of internal medicine, 2026
Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians
Annals of internal medicine, 2026
Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026)
Annals of internal medicine, 2026
Cardiovascular Outcomes in a SELECT-Like Obesity Cohort: Real-World Insights From the Swedish AROS Database
Diabetes, obesity & metabolism, 2026
Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G
Diabetes, obesity & metabolism, 2026
Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta-Analysis
Diabetes, obesity & metabolism, 2026
Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials
Diabetes, obesity & metabolism, 2026
Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026
Association between GLP-1 receptor agonist use and NAION with optic disc drusen
Ophthalmology, 2026